89 related articles for article (PubMed ID: 18293237)
1. Predictors of bacterial infections among HCV-negative injection drug users in Rhode Island.
Phillips KT; Anderson BJ; Stein MD
Am J Drug Alcohol Abuse; 2008; 34(2):203-10. PubMed ID: 18293237
[TBL] [Abstract][Full Text] [Related]
2. HIV and HCV testing for young drug users in Rhode Island.
Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
[TBL] [Abstract][Full Text] [Related]
3. A success story: HIV prevention for injection drug users in Rhode Island.
Beckwith CG; Moreira CC; Aboshady HM; Zaller N; Rich JD; Flanigan TP
Subst Abuse Treat Prev Policy; 2006 Dec; 1():34. PubMed ID: 17144920
[TBL] [Abstract][Full Text] [Related]
4. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
6. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).
Kapadia F; Latka MH; Hagan H; Golub ET; Campbell JV; Coady MH; Garfein RS; Thomas DL; Bonner S; Thiel T; Strathdee SA
J Urban Health; 2007 Jan; 84(1):99-115. PubMed ID: 17200799
[TBL] [Abstract][Full Text] [Related]
7. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X; Luo J; Bai J; Yu R
Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
[TBL] [Abstract][Full Text] [Related]
9. Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA
BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
[TBL] [Abstract][Full Text] [Related]
11. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
12. Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS
Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406
[TBL] [Abstract][Full Text] [Related]
13. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD; Thiede H; Hagan H
Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C infection among drug users in northern Thailand.
Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
16. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
Li D; Zheng X; Zhang G
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):74-5. PubMed ID: 7522968
[TBL] [Abstract][Full Text] [Related]
19. A trial to reduce hepatitis C seroincidence in drug users.
Stein MD; Herman DS; Anderson BJ
J Addict Dis; 2009 Oct; 28(4):389-98. PubMed ID: 20155608
[TBL] [Abstract][Full Text] [Related]
20. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
